These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 625539)

  • 1. Prolactin and neuroleptics: clinical implications for efficacy and toxicity. The effect of neuroleptics and alpha-methyl-para-tyrosine on serum prolactin levels in laboratory animals and man.
    Meltzer HY; Fang VS; Goode DJ
    Psychopharmacol Bull; 1978 Jan; 14(1):5-7. PubMed ID: 625539
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of alpha-methyl-p-tyrosine, adrenolytic compounds, pimozide and other neuroleptics, on the narcotic cue.
    Colpaert FC; Niemegeers CJ; Janssen PA
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):308-16. PubMed ID: 849077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of some psychoactive agents on prolactin secretion in rats of different endocrine states.
    Clemens JA; Shaar CJ; Smalstig EB; Matsumoto C
    Horm Metab Res; 1974 May; 6(3):187-90. PubMed ID: 4834662
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat.
    Nash JF; Meltzer HY
    J Pharmacol Exp Ther; 1989 Apr; 249(1):236-41. PubMed ID: 2565390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man.
    Meltzer HY; Fleming R
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):76-9. PubMed ID: 6130077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed activation of tuberoinfundibular dopamine neurons and suppression of prolactin secretion in the rat after morphine administration.
    Gudelsky GA; Passaro E; Meltzer HY
    J Pharmacol Exp Ther; 1986 Mar; 236(3):641-5. PubMed ID: 3950867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of brain catecholamine synthesis and release of prolactin and luteinizing hormone in the ovariectomized rat.
    Carr LA; Conway PM; Voogt JL
    J Pharmacol Exp Ther; 1975 Jan; 192(1):15-21. PubMed ID: 1123720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 9. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
    Meltzer HY; Fessler RG; Fang VS
    Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin levels and amphetamine-induced behavioural changes following fluphenazine decanoate administration.
    Merali Z
    Prog Neuropsychopharmacol; 1981; 5(5-6):603-7. PubMed ID: 7339653
    [No Abstract]   [Full Text] [Related]  

  • 11. [The biochemical effects of a new antidepressive, metapramine (RP 19560) on activity of the dopaminergic and cholinergic systems of the rat striatum].
    Boireau A; Garret C; Blanchard JC
    J Pharmacol; 1986; 17(1):75-84. PubMed ID: 2872367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.
    Fuxe K; Hökfelt T; Ljungdahl A; Agnati L; Johansson O; Perez de la Mora M
    Med Biol; 1975 Jun; 53(3):177-83. PubMed ID: 1160412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin causes increased turnover of dopamine in 10-day-old rat median eminence.
    Silverman WF; Walsh RJ
    Anat Rec; 1987 Jan; 217(1):53-5. PubMed ID: 3454564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neuroleptics on endogenous norepinephrine in rat brain.
    Bartholini G; Keller HH; Pletscher A
    Neuropharmacology; 1973 Aug; 12(8):751-6. PubMed ID: 4746440
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible involvement of dopaminergic mechanisms in the action of tranquilizing agents].
    Carenzi A; Canal N; Frattola L; Trabucchi M
    Acta Neurol (Napoli); 1976; 31(2):146-61. PubMed ID: 188311
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid decrease of plasma prolactin levels in lactating rats separated from their pups.
    Nagy G; Bánky Z; Takács L
    Endocrinol Exp; 1983 Oct; 17(3-4):311-6. PubMed ID: 6606569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolactin response in clinical psychiatry.
    Gruen PH
    Med Clin North Am; 1978 Mar; 62(2):409-24. PubMed ID: 347199
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased ability of apomorphine to reduce serum concentrations of prolactin in rats treated chronically with alpha-methyltyrosine.
    Annunziato L; Moore KE
    Life Sci; 1977 Dec; 21(12):1845-9. PubMed ID: 604710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.